CoChat

Remission status defined by immunofixation vs. electrophoresis after autologous transplantation has a major impact on the outcome of multiple myeloma patients

Open access
Lahuerta, Juan José, Martinez‐Lopez, Joaquín, Serna, Javier de la, Bladé, Joan, Grande, Carlos, Alegre, Adrián, Vazquez, Lourdes, García‐Laraña, José, Sureda, Ana, Rubia, Javier de la, Conde, Eulogio, Martinez, Rafael, Perez‐Equiza, Katy, Moraleda, José M., León, Angel, Besalduch, Juan, Cabrera, Rafael, Miguel, José D. Gonzalez‐San, Morales, Alfonso, García‐Ruíz, Juan C., Diaz‐Mediavilla, Joaquín, San‐Miguel, Jesús, for the G ethand P ETHEMA G roups · 2000 · British Journal of Haematology
Cited by 107

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

We have retrospectively analysed 344 multiple myeloma (MM) patients (202 de novo patients) treated in a non‐uniform way in whom high‐dose therapy and autologous stem cell transplantation (ASCT) response was simultaneously measured by both electrophoresis (EP) and immunofixation (IF). Patients in complete remission (CR) by EP were further subclassified as CR1 when IF was negative and CR2 when it remained positive. Partial responders (PR) were also subclassified as PR1 (very good PR, > 90% reduction in M‐component) or PR2 (50–90% reduction). CR1 patients showed a significantly better event‐free survival (EFS) [35% at 5 years, 95% confidence interval (CI) 17–53, median 46 months] and overall survival (OS) (72% at 5 years, CI 57–86, median not reached) compared with any other response group (univariate comparison P < 0·00000 to P = 0·004). In contrast, comparison of CR2 with PR1 and with PR2 did not define different prognostic subgroups (median EFS 30, 30 and 26 months respectively, P = 0·6; median survival 56, 44 and 42 months respectively, P = 0·5). The non‐responding patients had the worst outcome (5‐year OS 8%, median 7 months). Multivariate analysis confirmed both the absence of differences among CR2, PR1 and PR2 and the highly discriminatory prognostic capacity of a three‐category classification: (i) CR1 (ii) CR2 + PR1 + PR2, and (iii) non‐response (EFS P < 0·00000; OS P < 0·00000; both Cox models P < 0·00000). In the logistic regression analysis, the factors significantly associated with failure to achieve CR1 were the use of two or more up‐front chemotherapy lines, status of non‐response pre‐ASCT and inclusion of total body irradiation (TBI) in the preparative regimen. Tandem transplants or the use of multiple agents (busulphan and melphalan) in the preparative regimen resulted in a higher CR1 level; none of the biological factors explored influenced the possibility of achieving CR1. These results confirm that, in MM patients undergoing ASCT, achieving a negative IF identifies the patient subset with the best prognosis; accordingly, therapeutic strategies should be specifically designed to achieve negative IF.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1365-2141.2000.02012.x

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 107

Metadata

Authors
Lahuerta, J. J., Martinez‐Lopez, J., Serna, J. D. L., Bladé, J., Grande, C., Alegre, A., Vazquez, L., García‐Laraña, J., Sureda, A., Rubia, J. D. L., Conde, E., Martinez, R., Perez‐Equiza, K., Moraleda, J. M., León, A., Besalduch, J., Cabrera, R., Miguel, J. D. G., Morales, A., García‐Ruíz, J. C., Diaz‐Mediavilla, J., San‐Miguel, J., & roups, F. T. G. E. P. E. G.
Venue
British Journal of Haematology
Publisher
Wiley
Published
2000-05
Volume
109
Issue
2
Pages
438-446
ISSN
  • 0007-1048 (ISSN-L)
  • 1365-2141
OpenAlex
W1977950751
Cited by
107
References
1
FWCI
3.32
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Remission status defined by immunofixation vs. electrophoresis after autologous transplantation has a major impact on the outcome of multiple myeloma patients. https://app.cochat.ai/papers/10.1046/j.1365-2141.2000.02012.x
The paper
Lahuerta, J. J., Martinez‐Lopez, J., Serna, J. D. L., Bladé, J., Grande, C., Alegre, A., Vazquez, L., García‐Laraña, J., Sureda, A., Rubia, J. D. L., Conde, E., Martinez, R., Perez‐Equiza, K., Moraleda, J. M., León, A., Besalduch, J., Cabrera, R., Miguel, J. D. G., Morales, A., . . . roups, F. T. G. E. P. E. G. (2000). Remission status defined by immunofixation vs. electrophoresis after autologous transplantation has a major impact on the outcome of multiple myeloma patients. British Journal of Haematology. https://doi.org/10.1046/j.1365-2141.2000.02012.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.